JP2022506272A5 - - Google Patents

Info

Publication number
JP2022506272A5
JP2022506272A5 JP2021523494A JP2021523494A JP2022506272A5 JP 2022506272 A5 JP2022506272 A5 JP 2022506272A5 JP 2021523494 A JP2021523494 A JP 2021523494A JP 2021523494 A JP2021523494 A JP 2021523494A JP 2022506272 A5 JP2022506272 A5 JP 2022506272A5
Authority
JP
Japan
Prior art keywords
animal
gastrointestinal barrier
permeability
oligosaccharide preparation
nutritional composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021523494A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022506272A (ja
JP7426548B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/060443 external-priority patent/WO2020097446A1/en
Publication of JP2022506272A publication Critical patent/JP2022506272A/ja
Publication of JP2022506272A5 publication Critical patent/JP2022506272A5/ja
Priority to JP2023211209A priority Critical patent/JP7699647B2/ja
Application granted granted Critical
Publication of JP7426548B2 publication Critical patent/JP7426548B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021523494A 2018-11-08 2019-11-08 胃腸の恒常性を支持する方法 Active JP7426548B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023211209A JP7699647B2 (ja) 2018-11-08 2023-12-14 胃腸の恒常性を支持する方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862757500P 2018-11-08 2018-11-08
US201862757465P 2018-11-08 2018-11-08
US62/757,465 2018-11-08
US62/757,500 2018-11-08
PCT/US2019/060443 WO2020097446A1 (en) 2018-11-08 2019-11-08 Methods of supporting gastrointestinal homeostasis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023211209A Division JP7699647B2 (ja) 2018-11-08 2023-12-14 胃腸の恒常性を支持する方法

Publications (3)

Publication Number Publication Date
JP2022506272A JP2022506272A (ja) 2022-01-17
JP2022506272A5 true JP2022506272A5 (cg-RX-API-DMAC7.html) 2022-08-23
JP7426548B2 JP7426548B2 (ja) 2024-02-02

Family

ID=70612501

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021523494A Active JP7426548B2 (ja) 2018-11-08 2019-11-08 胃腸の恒常性を支持する方法
JP2023211209A Active JP7699647B2 (ja) 2018-11-08 2023-12-14 胃腸の恒常性を支持する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023211209A Active JP7699647B2 (ja) 2018-11-08 2023-12-14 胃腸の恒常性を支持する方法

Country Status (10)

Country Link
US (2) US12251391B2 (cg-RX-API-DMAC7.html)
EP (2) EP3876750A4 (cg-RX-API-DMAC7.html)
JP (2) JP7426548B2 (cg-RX-API-DMAC7.html)
KR (2) KR102905799B1 (cg-RX-API-DMAC7.html)
CN (2) CN121058782A (cg-RX-API-DMAC7.html)
AU (2) AU2019376144B2 (cg-RX-API-DMAC7.html)
CA (1) CA3116021A1 (cg-RX-API-DMAC7.html)
MX (1) MX2021005374A (cg-RX-API-DMAC7.html)
WO (1) WO2020097446A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202102834B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2755042T3 (es) 2015-01-26 2020-04-21 Cadena Bio Inc Composiciones de oligosacáridos para el uso como alimento para animales y sus métodos para producirlas
WO2020097446A1 (en) * 2018-11-08 2020-05-14 Dsm Ip Assets, B.V. Methods of supporting gastrointestinal homeostasis
CN116033923A (zh) * 2020-08-12 2023-04-28 齐沃生物科学股份有限公司 Variovorax病菌作为球虫病替代治疗的用途
US20240000109A1 (en) * 2020-12-03 2024-01-04 Dsm Ip Assets B.V. Oligosaccharide formulation
CN116528688A (zh) * 2020-12-03 2023-08-01 帝斯曼知识产权资产管理有限公司 寡糖制剂
EP4294204A1 (en) * 2021-02-16 2023-12-27 DSM IP Assets B.V. Methods of selectively promoting animal welfare through modulation of microbiome
US20250041320A1 (en) * 2021-12-13 2025-02-06 Dsm Ip Assets B.V. Use of oligosaccharide preparation to increase performance of animal vaccinated against coccidiosis
EP4489584A1 (en) * 2022-03-09 2025-01-15 DSM IP Assets B.V. Improving layer bird performance using an oligosaccharide preparation
CN119604295A (zh) * 2022-07-29 2025-03-11 帝斯曼知识产权资产管理有限公司 使用寡糖制备物降低禽类坏死性肠炎影响
CN115944033B (zh) * 2022-12-12 2025-05-02 中国水产科学研究院黄海水产研究所 5-hmf在黄条鰤促生长和提高免疫力饲料添加剂及饲料中应用
CN116350642B (zh) * 2023-02-28 2025-10-17 中南民族大学 1,6-脱水-β-D-葡萄糖制备用于维持结肠上皮屏障和隐窝的完整性以及抗结肠炎的药品的应用
EP4687916A1 (en) * 2023-04-05 2026-02-11 DSM IP Assets B.V. Oligosaccharide preparation counteracting respiratory disease effect

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10104055A1 (de) * 2001-01-31 2002-08-14 Suedzucker Ag Verwendung von Kohlenhydraten zur Beseitigung von Darminfektionen bei Tieren
RU2450815C2 (ru) * 2005-12-16 2012-05-20 Н.В. Нютрисиа Применение растворимых пищевых волокон против мышечной атрофии
RU2429853C2 (ru) 2007-02-01 2011-09-27 Дзе Иамс Компани Способ уменьшения воспаления и окислительного стресса у млекопитающих
ES2304223B2 (es) * 2007-03-08 2009-05-01 Universidad De Sevilla Nuevos caramelos con elevado contenido en oligosacaridos prebioticos, procedimiento de preparacion y utilizacion.
KR101258902B1 (ko) 2008-12-31 2013-05-07 엘지디스플레이 주식회사 프리즘시트, 이를 구비한 백라이트장치 및 액정표시소자
GB0915315D0 (en) * 2009-09-03 2009-10-07 Univ Manchester Use of non-digestible oligosaccharides
RU2440121C2 (ru) * 2009-09-23 2012-01-20 Александр Владимирович Диковский Ветеринарная фармацевтическая композиция и способ (варианты) профилактики и лечения заболеваний жкт и интоксикаций различной этиологии у животных
CN102091089A (zh) * 2010-11-22 2011-06-15 国家海洋局第一海洋研究所 一种活性牛蒡寡糖在水产养殖中的应用
CA2864086C (en) 2011-02-28 2018-07-10 Midori Renewables, Inc. Polymeric acid catalysts and uses thereof
WO2014031956A1 (en) 2012-08-24 2014-02-27 Midori Renewables, Inc. Polymeric and solid-supported catalysts, and methods of digesting cellulosic materials using such catalysts
JP7158096B2 (ja) * 2014-07-09 2022-10-21 カデナ バイオ,インコーポレーテッド オリゴ糖組成物及びその生成方法
EP3862002A1 (en) 2015-01-26 2021-08-11 Kaleido Biosciences, Inc. Glycan therapeutics and related methods thereof
ES2755042T3 (es) 2015-01-26 2020-04-21 Cadena Bio Inc Composiciones de oligosacáridos para el uso como alimento para animales y sus métodos para producirlas
CA2975093A1 (en) * 2015-01-26 2016-08-04 Midori Usa, Inc. Oligosaccharide compositions for use in nutritional compositions, and methods of producing thereof
IL243707A0 (en) * 2016-01-20 2016-05-01 Galmed Res And Dev Ltd Treatment to regulate the microbiota in the intestine
ES2671175B1 (es) 2016-11-18 2019-03-13 Univ Granada Procedimiento de preparacion de caramelos con elevado contenido en oligosacaridos prebioticos
EP3589139A4 (en) * 2017-03-01 2020-12-23 Glycom A/S SYNTHETIC COMPOSITION FOR MICROBIOTE MODULATION
CN107897512A (zh) * 2017-11-30 2018-04-13 河南普尼尔生物制药有限公司 一种用于改善鸡肠道健康的肠道保健剂及其制备方法
WO2020097446A1 (en) * 2018-11-08 2020-05-14 Dsm Ip Assets, B.V. Methods of supporting gastrointestinal homeostasis

Similar Documents

Publication Publication Date Title
Dong et al. Astragalus polysaccharides attenuated inflammation and balanced the gut microflora in mice challenged with Salmonella typhimurium
Úbeda et al. Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats
Hashmat et al. Interleukin-6 inhibition attenuates hypertension and associated renal damage in Dahl salt-sensitive rats
JP2022506148A5 (cg-RX-API-DMAC7.html)
Ferenczi et al. Oligomannan prebiotic attenuates immunological, clinical and behavioral symptoms in mouse model of inflammatory bowel disease
CN110475551A (zh) 使用短链脂肪酸治疗和预防疾病和障碍
Chang et al. The suppressive effects of geniposide and genipin on Helicobacter pylori infections in vitro and in vivo
Chethan et al. Immunomodulatory potential of β-glucan as supportive treatment in porcine rotavirus enteritis
JP2017531673A5 (cg-RX-API-DMAC7.html)
JP2017526697A5 (cg-RX-API-DMAC7.html)
Paul et al. Cryptosporidiosis in goats: a review
WO2018200356A1 (en) Treating and preventing kidney damage
DE2409862C3 (de) Verwendung einer oral applizierbaren Immunoglobulinkombination
Xu et al. Effect of dietary bovine colostrum on the responses of immune cells to stimulation with bacterial lipopolysaccharide
Schnepf et al. Rotavirus susceptibility of antibiotic-treated mice ascribed to diminished expression of interleukin-22
Wang et al. Yeast β-glucan promotes antiviral type I interferon response via dectin-1
Kotková et al. The course of infection caused by Encephalitozoon cuniculi genotype III in immunocompetent and immunodeficient mice
Kogut et al. BT cationic peptides: Small peptides that modulate innate immune responses of chicken heterophils and monocytes
Caniglia et al. Septic funiculitis caused by S treptococcus equi subspecies equi infection with associated immune‐mediated haemolytic anaemia
Ha et al. Immunostimulation with Escherichia coli extract: prevention of recurrent urinary tract infections
Tran et al. Current and novel treatments for ulcerative colitis
JP2007504097A5 (cg-RX-API-DMAC7.html)
Wimsatt et al. Long-term and per rectum disposition of clarithromycin in the desert tortoise (Gopherus agassizii)
Amadori et al. Constitutive expression of interferons in swine leukocytes
JP2011026241A (ja) ワクチン及びその製造方法